Electron beam therapy in patients with scleredema.

treatment with diphencyprone. Z Hautkr 1984; 59: 1080 ± 1083. 3. Weisshaar E, Neumann H-J, Gollnick H. Successful treatment of disseminated facial verrucae with contact immunotherapy. Eur J Dermatol 1998; 8: 488 ± 491. 4. Greenberg JH, Smith TL, Katz RM. Verrucae vulgares rejection. A preliminary study on contact dermatitis and cellular immune response. Arch Dermatol 1973; 107: 580 ± 582. 5. Larsen PO. Contact immunotherapy of resistant warts with diphenylcyclopropenone. J Dermatol Treatment 1995; 6: 81 ± 83. 6. Orecchia G, Douville H, Santagostino L, Rabbiosi G. Treatment of multiple relapsing warts with diphencyprone. Dermatologica 1988; 177: 225 ± 231. 7. Rampen FHJ, Steijlen PM. Diphencyprone in the management of refractory palmoplantar and periungual warts: an open study. Dermatology 1996; 193: 236 ± 238. 8. Edwards L, Ferenczy A, Eron L, Baker D, Owens ML, Fox TL, et al. Self-administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol 1998; 134: 25 ± 30. 9. Beutner KR, Spruance SL, Hougham AJ, Fox TL, Owens ML, Douglas JM. Treatment of genital warts with an immuneresponse modi®er (imiquimod). J Am Acad Dermatol 1998; 38: 230 ± 239. 10. Tyring SK, Arany I, Stanley MA, Tomai MA, Miller RL, Smith MH, et al. A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod. J Infect Dis 1998; 178: 551 ± 555. 11. Beutner KR, Tyring SK, Trofatter KF, Douglas JM, Spruance S, Owens ML. Imiquimod, a patient-applied immune-response modi®er for treatment of external genital warts. Antimicrob Agents Chemother 1998; 42: 789 ± 794. 12. Testerman TL, Gerster JF, Imbertson LM, Reiter MJ, Miller RL, Gibson SJ, et al. Cytokine induction by the immunomodulators imiquimod and S-27609. J Leukoc Biol 1995; 58: 365 ± 372.